EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

GRPR‐Targeted Radionuclide Conjugates: A Molecular Evolution Perspective

Meng Li iD, Yu Liu, MengChao Cui iD, HongYu Li

Chemistry & Biodiversity · 2026-07 · 23 (7)

DOI: 10.1002/cbdv.71513 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, online erschienen am 28.07.2026. Verfasst von Meng Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: HTA Co., Ltd, Beijing, China. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Receptors, Bombesin, Neoplasms, Radioisotopes. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gastrin‐releasing peptide receptor (GRPR) serves as an important target for radiopharmaceutical conjugates in cancer diagnosis and therapy. This article systematically reviewed the evolution of GRPR‐targeted ligands: from early agonists whose clinical application was limited by side effects, to current antagonists with improved stability and tumor retention. Key structural optimizations include C‐terminal modifications of peptides, along with the design of linkers and chelators, which collectively enhance targeting capability and pharmacokinetic properties. Despite the significant progress achieved so far, challenges such as off‐target uptake and inadequate metabolic stability still remain. Future research should be directed toward elucidating structure–activity relationships and designing novel ligands, linkers and chelators to promote the development of more selective and efficient diagnostic and therapeutic radiopharmaceuticals for cancers with high GRPR expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiopharmaceuticalsReceptors, BombesinNeoplasmsRadioisotopesHumansAnimalsStructure-Activity RelationshipLigands

Stichwörter der Autor:innen

GRPRantagonistsradionuclide drug conjugates (RDCs)structure‐activity relationship (SAR)theranostics

Substanzen

RadiopharmaceuticalsReceptors, BombesinRadioisotopesLigands

Autor:innen und Institutionen

  • HTA Co., Ltd, Beijing, China.
  • China Isotopes & Radiation Corporation, China National Nuclear Corporation (CNNC), Beijing, China.
  • Beijing Normal University, Beijing, China.
  • Capital Normal University, Beijing, China.

ORCID-Profile: Meng Li, MengChao Cui

Zitieren

APA

Li, M., Liu, Y., Cui, M., & Li, H. (2026). GRPR‐Targeted Radionuclide Conjugates: A Molecular Evolution Perspective. Chemistry & Biodiversity, 23(7). https://doi.org/10.1002/cbdv.71513

Vancouver

Li M, Liu Y, Cui M, Li H. GRPR‐Targeted Radionuclide Conjugates: A Molecular Evolution Perspective. Chemistry & Biodiversity. 2026;23(7). doi:10.1002/cbdv.71513

BibTeX
@article{Li2026,
  author = {Li, Meng and Liu, Yu and Cui, MengChao and Li, HongYu},
  title = {GRPR‐Targeted Radionuclide Conjugates: A Molecular Evolution Perspective},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {7},
  doi = {10.1002/cbdv.71513}
}
Kostenlos starten →